Merck KGaA's Mavenclad, Roche's Perjeta win 'innovative' coverage deals with NHS

10th November 2017 Uncategorised 0

Cost watchdogs in England and pharma don’t always see eye to eye, but the sides are celebrating two new deals on Merck KGaA’s Mavenclad and Roche’s Perjeta.

More: Merck KGaA's Mavenclad, Roche's Perjeta win 'innovative' coverage deals with NHS
Source: fierce